Follow Us

 

YAZ Side Effects Lawsuit News Archive

Bayer Reserves $1.5 Billion To Settle Yaz Birth Control Lawsuits
- Ennis & Ennis News
03/07/2013 - Bayer AG, the manufacturer of Yaz birth control products has reserved over $1.5 billion to cover litigation and settlement costs resulting from its Yaz and Yasmin oral contraceptives. Bayer has previously reached agreements to pay $1 billion to settle the claims of over 4,800 women in the United States who were injured by the pills. The contraceptives caused blood clots, which resulted in heart attacks, strokes, pulmonary embolism and death.
READ MORE::

Yaz Lawsuits, Yasmin Lawsuits And Ocella Birth Control Lawsuits Continue To Settle
- Ennis & Ennis News
02/13/2013 - Over 10,000 women have filed claims based on injuries received from Yaz, Yasmin and Ocella birth control pills, making it one of the largest mass torts in recent history. Many of these cases are consolidated in the Federal MDL pending in the U.S. District Court for the Southern District of Illinois before Judge David Herndon.  Bayer aggressively marketed the popular birth control pills and they became America’s top-selling birth control pills. However, its unique formula also made the Yaz pills one of the most dangerous.
READ MORE::

Bayer Settles 3,490 Yaz and Yasmin Birth Control Claims for $750 Million
- Ennis & Ennis News
10/31/2012 - As of October 15, 2012, there were about 12,400 Yaz/Yasmin lawsuits pending in the United States, and an additional 720 pending claims that had not been filed, according to Bayer’s Quarterly Report.  Plaintiffs in these Yaz and Yasmin lawsuits allege that they suffered dangerous and potentially fatal side effects such as pulmonary embolism, deep vein thrombosis and stroke from the use of Yaz and Yasmin birth control pills.
READ MORE::

An FDA-funded Study Reveals Drospirenone-Containing Birth Control Pills Increase Risk of Blood Clots
- Ennis & Ennis News
10/22/2012 - A recent study showed a 77% increased risk of venous thromboembolic events and a double risk for arterial thrombotic events with the use of drospirenone-containing birth control pills, such as Yaz and Yasmin, when compared with the risk of four low dose estrogen birth control pills.  Interestingly, this study was led by the Kaiser Permanente Northern California Division of Research and funded by the U.S. Food and Drug Administration.
READ MORE::

Settlement Figures Rise in Yaz and Yasmin Lawsuits
- Ennis & Ennis News
05/09/2012 - More cases against Bayer, maker of Yaz and Yasmin, have begun to settle. Currently 651 cases have settled, which averages around $218,000 per case, where women suffered from life threatening blood clots, according to Bloomberg News.
READ MORE::

Bayer Settles 651 Yaz Blood Clot Claims for $142 Million
- Ennis & Ennis News
04/27/2012 - Bayer continues to settle Yaz/Yasmin birth control lawsuits involving blood clots that caused deep vein thrombosis or pulmonary embolism. Bayer reported in its 1st quarter Stockholders’ Newsletter 2012 that it reached an agreement to settle the claims of 651 plaintiffs for a total amount of $142 million, for an average of $218,000 a case. This number has increased over that past two weeks, wherein it was previously reported that Bayer had agreed to pay $110 million to settle about 500 Yaz side effects claims.
READ MORE::

Bayer Pays Over $110 Million to Settle Yaz Birth Control Cases
- Ennis & Ennis News
04/13/2012 - Bayer will pay at least $110 million to settle about 500 lawsuits wherein plaintiffs allege that Yaz/Yasmin birth control pills caused serious injuries of which Bayer knew, or should have known, and failed to warn, reports Bloomberg. Bayer officials agreed to pay an average of about $220,000 a case to resolve claims in involving fatal blood clots that can lead to heart attacks and stroke.
READ MORE::

New Birth Control Label Warns of Increased Blood Clot Risk
- Ennis & Ennis News
04/112012 - The U.S. Food and Drug Administration (FDA) has completed its review of studies involving drospirenone-containing birth control pills, such as Yaz and Yasmin and has concluded that these types of birth control pills increase the risk for dangerous blood clot. As a result, the FDA is requiring a label change to include this information.
READ MORE::

Ennis & Ennis, P.A. Questions Why the FDA Allowed Five Members to Sit on Yaz Birth Control Advisory Panel Despite Conflicts of Interest
- Ennis & Ennis News
01/17/2012 - In December 2011, a U.S. Food and Drug Administration (FDA) advisory panel voted 15-11 that the benefits of drospirenone-containing birth control pills, such as Yaz and Yasmin, outweigh the risks. Interestingly, though, an investigation by the Washington Monthly and the British Medical Journal (BMJ) found that at least four members of the committee have either done work for the drugs’ manufacturers or licensees or received research funding from them. The FDA made none of those financial ties public.
READ MORE::

Yaz Birth Control Case Ordered to Mediation
- Ennis & Ennis News
01/06/2012 - The first Yaz pulmonary embolism lawsuit that was scheduled to begin trial January 9, 2012 will not begin as planned. The Honorable David Herndon, who is the presiding judge on many Bayer birth control pill lawsuits, ordered the case to mediation. “This is a good sign for both parties to begin the process of a global resolution to the litigation,” commented attorney Holly Ennis of Ennis & Ennis, P.A.
READ MORE::

Yaz - Yasmin Birth Control Lawsuit Test Trials Scheduled to Begin Next Year
- Ennis & Ennis News
01/02/2012 - Bayer is facing more than 7000 lawsuits over its popular birth control pills Yaz and Yasmin over serious side effects such as blood clots, deep vein thrombosis (DVT), gallbladder disease, and other cardiovascular complications. Many of the lawsuits allege that Bayer failed to adequately warn about these risks.
READ MORE::

FDA Panel Protects Yaz Profits Over Women’s Safety
- Ennis & Ennis News
12/13/2011 - The US Food and Drug Administration (FDA) advisory committee voted 21-5 on Thursday that labeling on Bayer's popular Yaz and similar birth control pills is inadequate and should be revised to better reflect the higher risk of blood clots associated with these drugs, compared with older oral contraceptives. Ennis & Ennis, P.A. explains the panelists want the label to make clearer the potential risk of blood clots in the legs and lungs from taking the pills, and that clots can be fatal. Currently the label only informs women about the conflicting studies on the blood clot risks.
READ MORE::

Should the FDA Recall Yaz and Yasmin?
- Ennis & Ennis News
12/06/2011 - The Food and Drug Administration’s (FDA) primary responsibility is to ensure that all medications it evaluates and approves are safe for public use. The pharmaceutical companies presumably extensively research and test new medications and provide this data to the FDA’s Center for Drug Evaluation Research (CDER). Unfortunately, the CDER conducts no research or testing, rather it simply relies on the data provided to it by the drug company. Ennis & Ennis, P.A. questions this process.
READ MORE::

Smoking Gun Email Reveals Bayer Promoted Yaz For Uses Not Approved By FDA Explains Ennis & Ennis PA
- Ennis & Ennis News
12/01/2011 - Bayer unit officials may have intentionally sought to market Yaz birth control pills for unapproved uses and mislead consumers about the potential health risks associated with the drug, as evidenced in company emails, reported Bloomberg. "Considering that our clients had other birth control options available to them, yet detrimentally relied upon Yaz and all that it claimed to treat, when they actually had safer alternatives available to them, this would be a complete travesty," commented Attorney Holly Ennis of Ennis & Ennis, P.A.
READ MORE::

Judge Denies Request to Use Confidential Yaz Documents to Petition to FDA
Explains Ennis & Ennis, PA
Ennis & Ennis, P.A. Explains the Ruling that Certain Documents Involved in the Yaz Litigation Are Deemed Protected and Confidential
- Ennis & Ennis News
11/16/2011 - Last week Chief Judge David R. Herndon denied Plaintiff’s request to use certain “protected” documents from the Yaz litigation to petition the FDA and its advisory committee concerning public health issues associated with drospirenone-containing birth control pills, such as Yaz. Attorney David Ennis of Ennis & Ennis, P.A. commented on the ruling stating, “It’s a shame that certain documents are kept confidential, especially when they may include critical information for the FDA’s determination of the safety of Yaz; however it is understandable that the certain information is protected in order to preserve the discovery process.”
READ MORE::

Yet Another Study Confirms Yaz Increases Risk of Blood Clots
Ennis & Ennis, P.A. explains the findings of another recent study revealing the significant risk of developing dangerous blood blots associated with birth control pills such as Yaz and Yasmin.
- Ennis & Ennis News
11/09/2011 - The Canadian Medical Association Journal released a study of 330,000 Israeli women indicating that blood clots were more likely for those who were taking Yaz and Yasmin, which are birth control pills that contain the synthetic hormone drospirenone, reported attorney David Ennis.
READ MORE::

FDA Issues Safety Communication on Birth Control Pills Yaz, Yasmin and Other Drospirenone Pills
- Ennis & Ennis News
09/28/2011 - On September 26, 2011, the U.S. Food and Drug Administration (FDA) released a Safety Communication reporting that it “remained concerned” about the potential increased risk of blood clots associated with the use of drospirenone-containing birth control pills. http://www.fda.gov/Drugs/DrugSafety/ucm273021.htm Drospirenone is the synthetic progestin ingredient used in certain birth control pills such as Yaz, Yasmin, Safyal, Beyaz and Zarah (name brands) and Ocella (generic).
READ MORE::

Yaz Gallbladder Removal Lawsuit Filed Against Bayer By Woman
- Ennis & Ennis News
01/29/2010 - A Michigan woman has filed a lawsuit against Bayer over its popular birth control pill Yaz, alleging that side effects caused her to have her gallbladder removed and suffer blood clots. The Yaz lawsuit was filed yesterday in the U.S. District Court for the Eastern District of Michigan by Asia Moore. It is among hundreds of other cases pending against the makers of Yaz that involve allegations that the drug maker failed to adequately research the potential side effects of Yaz or warn about the increased risk of gallbladder disease, stroke, heart attack, pulmonary embolism, deep vein thrombosis or sudden death.
READ MORE::

If you or a loved one have suffered serious injury or death while using Yasmin, Yaz or the generic product Ocella, you may be entitled to compensation. Contact the birth control side effects lawyers of Ennis & Ennis, P.A. today for a free nationwide case evaluation. Our experienced attorneys can answer any questions you may have about Yaz, Yasmin, or Ocella side effects or a potential Yaz, Yasmin, Ocella lawsuit. Fill out the case evaluation form on this page or call toll free: 1-800-856-6405.

Under no circumstances should you discontinue taking any medication, including Accutane, without first consulting with your doctor.

Yaz Side Effects Lawsuit